BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33955519)

  • 1. Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression.
    Cai S; Sun Z; Sun PH; Gao X; Ji K; Tian X; Ji J; Hao C; Soliman F; Liu C; Al-Sarireh B; Griffiths P; Hiscox S; Jiang WG; Ye L
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase D-interacting Substrate of 220 kDa Is Overexpressed in Gastric Cancer and Associated With Local Invasion.
    Cai S; Sun Z; Gao X; Ji KE; Ruge F; Shankla D; Liu X; Jiang WG; Ye L
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):735-743. PubMed ID: 38035704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer.
    Morimoto M; Horikoshi Y; Nakaso K; Kurashiki T; Kitagawa Y; Hanaki T; Sakamoto T; Honjo S; Umekita Y; Fujiwara Y; Matsura T
    Cancer Lett; 2020 Feb; 470():149-160. PubMed ID: 31765735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
    Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
    Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma.
    Tian C; Öhlund D; Rickelt S; Lidström T; Huang Y; Hao L; Zhao RT; Franklin O; Bhatia SN; Tuveson DA; Hynes RO
    Cancer Res; 2020 Apr; 80(7):1461-1474. PubMed ID: 32029550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
    Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
    J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway.
    Wang C; Wei Y; Wang G; Zhou Y; Zhang J; Xu K
    Oncol Rep; 2020 Aug; 44(2):711-721. PubMed ID: 32627022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
    Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
    Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
    Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
    J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.
    Liu Y; Bunston C; Hodson N; Resaul J; Sun PH; Cai S; Chen G; Gu Y; Satherley LK; Bosanquet DC; Al-Sarireh B; Tian X; Hao C; Jiang WG; Ye L
    Int J Oncol; 2017 May; 50(5):1491-1500. PubMed ID: 28393239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
    Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
    J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling.
    Xie ZB; Zhang YF; Jin C; Mao YS; Fu DL
    J Exp Clin Cancer Res; 2019 Feb; 38(1):75. PubMed ID: 30760292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
    Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
    Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V
    Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.